In this episode of #ExpertAnswers, Dr. Peter Ansell from AbbVie and Dr. Marian Navratil from HTG answer questions from a webinar where they discuss the use of novel RNA-based gene expression profiling technologies for clinical and preclinical oncology research.
For more information or to watch the webinar, click here.